Syngene International Ltd. - Research Center
539268 SYNGENE Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 3,203.10 | 3,193.50 | 2,601.40 | 2,179.40 | 2,011.90 |
| Operating profit | 878.80 | 934.30 | 793.40 | 670.00 | 616.70 |
| Interest | 29.50 | 45.20 | 24.10 | 27.70 | 34.60 |
| Gross profit | 937.30 | 960.00 | 822.10 | 706.90 | 663.70 |
| EPS (Rs) | 11.60 | 11.78 | 9.83 | 10.09 | 10.29 |
Annual
results in details
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 88.00 | 70.90 | 52.80 | 64.60 | 81.60 |
| Stock adjustment | 56.60 | -42.00 | -21.60 | -25.20 | 0.80 |
| Raw material | 839.10 | 902.20 | 770.60 | 551.70 | 518.60 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 761.20 | 812.20 | 697.80 | 641.50 | 572.20 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 667.40 | 586.80 | 361.20 | 341.40 | 303.60 |
| Provisions made | - | - | - | - | - |
| Depreciation | 368.90 | 359.10 | 309.70 | 274.50 | 219.30 |
| Taxation | 90.80 | 127.90 | 87.90 | 63.70 | 104.20 |
| Net profit / loss | 466.50 | 473.00 | 393.80 | 403.70 | 411.50 |
| Extra ordinary item | -11.10 | - | -30.70 | 35.00 | 71.30 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 402.00 | 401.40 | 400.80 | 400.00 | 400.00 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 27.44 | 29.26 | 30.50 | 30.74 | 30.65 |
| GPM (%) | 28.48 | 29.41 | 30.97 | 31.50 | 31.70 |
| NPM (%) | 14.17 | 14.49 | 14.84 | 17.99 | 19.66 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis